This protocol describes in vitro procedures for generation of synthetic single-domain antibodies called ‘sybodies’. Sybodies can be engineered to target specific protein conformations, labile membrane proteins or protein complexes.
- Iwan Zimmermann
- Pascal Egloff
- Markus A. Seeger
